2007 Annual Meeting - Information

2007 Schedule at a Glance

Wednesday March 14, 2007
8:00 AM - 3:00 PM	Exhibitor and Poster Set up
5:00 - 6:30 PM	Welcome Reception in Exhibit Hall Supported by The Alliance for Better Bone Health: sanofi-aventis Pharmaceuticals and P&G Pharmaceuticals
5:00 - 6:30 PM	Exhibits and Posters Hours
6:30 - 8:30 PM	Satellite Symposium Emerging Evidence in the Differences Between Bisphosphonates - R. Graham Russell, PhD, Nelson B. Watts, MD, CCD, and Robert Lindsay, MD The University of Cincinnati is not the accredited provider for this session Supported by The Alliance for Better Bone Health: sanofi-aventis Pharmaceuticals and P&G Pharmaceuticals
Thursday, March 15, 2007
7:00 - 8:00 AM	Hologic Hands on Workshop– Susan Broy, MD, CCD and Stephen Robertson, CDT (This session does not carry an additional fee, but seating is limited to 30 attendees.)
7:00 - 8:00 AM	Meet the Professor Breakfast Sessions (Additional fee applies. Seating is limited to 30 attendees. $40 each.) Tamara Vokes, MD, CCD - Osteoporosis Introduction: Clinical Evaluation of the Osteoporotic Patient Laura Bachrach, M.D. - BMD in Children Ken Faulkner, PhD - Manufacturer Variability in BMD
8:00 - 8:10 AM	Welcome – President and Co-chairs
8:10 - 9:40 AM	General Session Absolute Fracture Risk: An Update Bess Dawson-Hughes, MD John A. Kanis, MD
9:30 AM - 1:30 PM	Exhibits and Poster Hours
9:40 - 10:10 AM	Break in Exhibit Hall (Case of the Day)
10:10 - 11:10 AM	Concurrent Sessions Estrogen after the WHI, *Wendy Kohrt, PhD* Treatment of Osteoporosis: New Therapeutic Horizons, Michael McClung, MD Anti-Resorptive Agents Anabolic Therapy Fracture Probability: What Does this Mean for the Technologist? – E. Michael Lewiecki, MD, CCD
11:10 AM - 12:10 PM	Concurrent Sessions Low BMD in Premenopausal Women, Elizabeth Shane, MD Treatment of Osteoporosis in the Nursing Home - Diane Schneider, MD, MSc, CCD Clinical Relevance of New Software Features: Are the Bells and Whistles Helpful? – Lawrence Jankowski, CDT
12:10 - 1:30 PM	Lunch in Exhibit Hall Supported by Hologic, Inc.
12:30– 1:30 PM	Even Numbered Poster Authors Present in Exhibit Hall
12:30 - 1:30 PM	GE Hands on Workshop, Edward Leib, MD, CCD and Anita Colquhoun, RT, CDT (This session does not carry an additional fee, but seating is limited to 30 attendees.)
12:30 - 1:30 PM	Meet the Professor Lunch Sessions (Additional fee applies. Seating is limited to 30 attendees. $40 each.) Mary Oates, MD - Rehabilitation: Its Role in the Osteoporotic Patient John Bilezikian, MD, CCD - Male Osteoporosis Steven M. Petak, MD, JD, CCD - Osteoporosis Introduction: Laboratory Evaluation of the Osteoporotic Patient
1:30 – 2:30 PM	Concurrent Sessions Eating Disorders and Peak Bone Mass Steve Crawford, MD Drugs Interfering with Normal Bone Metabolism Anticonvulsant Therapy - E. Michael Lewiecki, MD, CCD Advanced Bone Densitometry Advanced Hologic - Sergio Ragi-Eis, MD, CCD, CDT
2:30 - 3:30 PM	Concurrent Sessions Pediatric Bone Metabolism How Should We Report BMD in Children - Laura Bachrach, MD Drugs Interfering with Normal Bone Metabolism Androgen and Estrogen Blockade - Marjorie Luckey, MD, CCD Advanced Bone Densitometry Advanced GE - JoAnn Caudill, RT, CDT
3:30 - 4:30 PM	Concurrent Sessions Bisphosphonates Physiology - R. Graham Russell, PhD International Guidelines Canadian: Aliya A. Khan, MD, CCD Iberian American – Sergio Ragi-Eis, MD, CCD Advanced Bone Densitometry Advanced Norland - Adrian K. Turner, BSc, CDT
4:30 - 7:00 PM	Exhibit Hall and Poster Hours
4:30 - 5:00 PM	Break in the Exhibit Hall
5:00 - 6:00 PM	Interactive Debate: Osteoporosis Treatment: IsThere a Role for Hormonal Therapy? Wendy Kohrt, PhD and Elizabeth Barrett-Connor, MD
6:00 - 7:00 PM	Satellite Symposium Reception
7:00 - 9:00 PM	Satellite Symposium Down to the Bone: Issues in the Maintenance and Evaluation of Bone Health -Sydney Bonnick, MD, CCD, M. Susan Burke, MD,, Robert Heaney, MD and Anthony Sebba, MD The University of Cincinnati is not the accredited provider for this session Supported by Merck
Friday, March 16, 2007
7:00 - 8:00 AM	Hologic Hands on Workshop - Brian Lentle, MD,CCD and Rogene Tesar, PhD, CCD, CDT (This session does not carry an additional fee, but seating is limited to 30 attendees.)
7:00 - 8:00 AM	Radiation Safety - Ken Faulkner, PhD
7:00 - 8:00 AM	Meet the Professor Breakfast Sessions (Additional fee applies. Seating is limited to 30 attendees. $40 each.) Sundeep Khosla, MD - Update on SARMs & Testosterone Stuart L. Silverman, MD - The WHO Model and the Densitometrist Robert P. Heaney, MD - Nutrition and Bone Health
8:00 - 9:00 AM	General Session Vitamin D, Bones and Beyond - Robert P. Heaney, MD
9:00 - 10:00 AM	Concurrent Sessions Facility Accreditation: How to Build a Standard Operating Procedures (SOP) Document - Laura Fairbanks, MS and Wendy Tolman, BS, RT, CDT Total Body Composition and Metabolic Syndrome - Mary Oates, MD Best Technologist Abstracts/Writing Posters/Papers – Susan Broy, MD, CCD
10:00 AM - 2:00 PM	Exhibits and Poster Hours
10:00 - 10:30 AM	Break in Exhibit Hall (Case of the Day)
10:30 - 11:30 AM	GE Hands on Workshop - Gary Edelson, MD,CCD and *Anita Colquhoun RT, CDT* (This session does not carry an additional fee, but seating is limited to 30 attendees.)
10:30 - 11:30 AM	Concurrent Sessions Treatment Options for Low Bone Mass in Chronic Kidney Disease - Paul Miller, MD, CCD What to Do When Phantoms Shift or Drift and How to Cross Calibrate - Ken Faulkner, PhD
11:30 AM - 12:30 PM	Concurrent Sessions What is the Relationship Between the Skeletal and Cardiovascular System? - Sundeep Khosla, MD Non-Standard Skeletal Assessment: MRI, CT and X-ray - Harry Genant, PhD
12:30 - 1:45 PM	Box Lunch in Exhibit Hall
12:45 - 1:45 PM	Odd Numbered Poster Authors Present in Exhibit Hall
12:45 - 1:45 PM	Hologic Hands on Workshop – Sarah L. Morgan, MD, RD, CCD and Bennié L. Leverich, RN, CDT (This session does not carry an additional fee, but seating is limited to 30 attendees.)
12:45 - 1:45 PM	Meet the Professor Lunch Sessions (Additional fee applies. Seating is limited to 30 attendees. $40 each.) Didier B. Hans, PhD, PD, CCD - Peripheral Update Michael McClung, MD - Clinical Differences Between Bisphosphonates R. Graham Russell, PhD - Biochemistry of Bisphosphonates
1:45 - 3:45 PM	Concurrent Sessions Long Term Safety of the Bisphosphonates- Stuart L. Silverman, MD and David Pendrys
1:45 - 2:45 PM	Concurrent Sessions Conducting Literature Reviews/Top 2006 DXA Papers - Edward Leib, MD, CCD
2:45 - 3:45 PM	Concurrent Sessions VFA Acquisition and Analysis - Tamara Vokes, MD, CCD and Pamela C. Johnson, RT, CDT
3:45 - 7:45 PM	Exhibit Hall and Poster Hours
3:45 - 4:15 PM	Break in the Exhibit Hall
4:15 - 5:15 PM	Satellite Symposium The Basic Biology of Bone -- Osteoclasts, Osteoblasts and Osteocytes –David W. Dempster, PhD Supported by Amgen
5:15 - 6:00 PM	Public Policy Discussion of DXA Reimbursement
6:00 - 7:00 PM	General Session Bonehead Jeopardy - Nelson B. Watts, MD, CCD, Michael McClung, MD, and Stuart L. Silverman, MD
7:00 - 7:45 PM	Satellite Symposium Reception
7:45 - 9:45 PM	Satellite Symposium Current Controversies in Osteoporosis - Paul Miller, MD, CCD, Joyce Cramer, Solomon Epstein, MD, and David Burr, PhD The University of Cincinnati is not the accredited provider for this session Supported by GSK/Roche
Saturday, March 17, 2007
7:00 - 8:00 AM	GE Hands on Workshop - Neil Binkley, MD, CCD and Gerald Avery, RT, CNMT, CDT (This session does not carry an additional fee, but seating is limited to 30 attendees.)
7:00 - 8:00 AM	Meet the Professor Breakfast Sessions (Additional fee applies. Seating is limited to 30 attendees. $40 each.) Marjorie Luckey, MD, CCD - Absolute Fracture Risk: How Can We Use it in Our Clinical Practices? John Bilezikian, MD, CCD - Male Osteoporosis Solomon Epstein, MD - Acute Rapid Bone Loss
8:00 - 9:00 AM	General Session Interactive Debate: Do We Need a BMD for Every Fracture Patient? Nelson B. Watts, MD, CCD and Michael Kleerekoper, MD, CCD
9:00 - 10:00 AM	Concurrent Sessions Six Most Relevant Bone Articles this Year - Solomon Epstein, MD Secondary Hyperparathyroidism Effects of Vitamin D Analogs and Calcimimetics on Bone - Daniel W. Coyne, MD How a Technologist Can Answer Patient Questions on Nutrition, Medication and DXA - Joyce Bemiller, RT, CDT
10:00 - 10:30 AM	Break in Foyer
10:30- 11:30 AM	Concurrent Sessions Primary Hyperparathyroidism: Should We Still Consider Patients for Medical Management - John Bilezikian, MD, CCD Challenging Case Presentation (formerly know as Stump the Professor) - Michael McClung, MD Peripheral Bone Density Update - Didier B. Hans, PhD, PD, CCD
11:30 AM - 12:30 PM	Concurrent Sessions Non-Caucasian Databases and Fracture Risk - E. Michael Lewiecki, MD, CCD Bone Strength Assessed with DXA - John A. Shepherd, PhD, CCD Why We Order Bone Densitometry? - Rogene Tesar, PhD, CCD, CDT
12:30 - 2:00 PM	Presidential Lunch and Public Policy Forum
2:00 - 3:15 PM	Leadership and Committee Workshop
7:30 - 10:30 PM	Special Event: ISCD St. Patrick’s Day Party

Program Event

The 2007 Annual Meeting is preceded by educational and certification opportunities. The Clinician and Technologist Bone Densitometry Courses will be offered on March 13-14. The Clinician and Technologist Bone Densitometry Certification Exams will be offered on March 14th. Click here to register for these programs.

The 2007 Annual Meeting will be followed by an educational opportunity, the Vertebral Fracture Assessment (VFA) Course will be offered on March 17th. Click here to register for this program.

Program Overview

The incidence and economic impact of osteoporotic fractures continue to grow as our population ages. It has been suggested that osteoporosis is a pediatric disease that is expressed years later. Thus, the long-term skeletal effect of societal lifestyle changes on children and younger adults is of concern. Dissemination of information regarding low bone mass, fracture risk, diagnosis and intervention among health care providers is crucial. Definition and implementation of diagnostic and treatment recommendations, based on estimation of fracture risk, will have a major impact on patient care. Emerging advances and diversification of dual-energy x-ray (DXA) technology are expanding the clinical utility of bone densitometers. The continuing advances in the field of osteoporosis and the aging of the American population support the need for further education of professionals involved with skeletal health.

Target Audience

The target audience for this educational activity is clinicians, technologists, researchers, scientists, and healthcare providers who wish to learn skills and techniques in quality skeletal assessment to implement into their practice.

Learning Objectives

Upon completion of this activity, participants should be able to:

Summarize basic skeletal biology and bone mass assessment to establish a foundation on which to build a more advanced knowledge of skeletal health.
Identify changes to diagnostic and treatment guidelines as they are affected by the implementation of absolute fracture risk
Recognize the affect that disease states and their management have on bone health
Discuss the impact that technical advances in the field of dual-energy x-ray (DXA) technology could have on clinical practice
Compare and contrast current and emerging therapies to treat osteoporosis and reduce fracture risk

Accreditation Statement

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Cincinnati and the International Society for Clinical Densitometry. The University of Cincinnati College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor CME for physicians.

Credit Designation

The University of Cincinnati College of Medicine designates this educational activity for a maximum of 24.5 AMA PRA Category 1 Credits™. Each physician should claim only those credits that he/she actually spent in the educational activity.

The University of Cincinnati College of Medicine is committed to resolving all conflict of interest issues which may arise as a result of prospective faculty members significant relationships with drug or device manufacturers. Our mandate is to retain only those speakers with financial interest that can be reconciled with the goals and educational integrity of the program.

CE Credit

The meeting qualifies for up to 23.5 category A credits through the ASRT..

Policy on Commercial Support and Faculty Disclosure

The ISCD maintains a policy on the use of commercial support which ensures that all educational activities supported by the ISCD provide in-depth presentations that are fair, independent, free of commercial bias and scientifically rigorous. To this end, all speakers are required to complete a Conflict of Interest Disclosure Form. All disclosures will be included in the program book.

Clinicians - CME Certificates

Full instructions for completing your evaluation of the 2007 Annual Meeting will be included in the program book. A CME certificate will be created during that process for you to print for your records.

Technologists - CE Certificates

If you would like to receive Category A CE credit for the 2007 Annual Meeting, see the instructions provided on the back of the CE Verification Form that is part of your registration materials. Note that there are two steps that must be completed in order to receive your CE Certificate acceptable for ISCD recertification and ASRT credit.